Plain-English translation of NCT06591351 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After a minor stroke caused by a large blocked blood vessel, your body needs medicine to prevent another stroke from happening. This trial compares two different combinations of blood-thinning drugs: one group will take cilostazol plus aspirin, while another group will take plus aspirin. Both combinations include aspirin, but the study is testing whether one medication works better than the other at keeping you safe over the next 90 days.
Doctors want to know which combination of blood-thinning drugs is safest and most effective at preventing a second stroke after a minor stroke caused by a large blood vessel blockage. This medication comparison will help determine the best treatment strategy for future patients.
You will be randomly assigned to one of two medication groups and will take your assigned blood-thinning combination daily for 90 days. During this time, you'll have clinic visits on day 7 and at 90 days, plus brain imaging (MRI and CT scans) within the first couple of days. You'll also have blood tests and heart monitoring if needed. The study team will check how well you're recovering and watch carefully for any side effects or signs of bleeding.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Egypt